Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Paul R. J. Ames, Tommaso Bucci, Mira Merashli, Marta Amaral, Alessia Arcaro, Fabrizio Gentile, Jaffar Nourooz-Zadeh & Jose DelgadoAlves. (2018) Oxidative/nitrative stress in the pathogenesis of systemic sclerosis: are antioxidants beneficial?. Free Radical Research 52:10, pages 1063-1082.
Read now
Read now
Debendra Pattanaik, Monica Brown & Arnold E Postlethwaite. (2011) Vascular involvement in systemic sclerosis (scleroderma). Journal of Inflammation Research 4, pages 105-125.
Read now
Read now
Christos G Mihos & Orlando Santana. (2011) Pleiotropic effects of the HMG-CoA reductase inhibitors. International Journal of General Medicine 4, pages 261-271.
Read now
Read now
Articles from other publishers (21)
Laura Ross, Nancy Maltez, Michael Hughes, Jan W Schoones, Murray Baron, Lorinda Chung, Dilia Giuggioli, Pia Moinzadeh, Yossra A Suliman, Corrado Campochiaro, Yannick Allanore, Christopher P Denton, Oliver Distler, Tracy Frech, Daniel E Furst, Dinesh Khanna, Thomas Krieg, Masataka Kuwana, Marco Matucci-Cerinic, Janet Pope & Alessia Alunno. (2023) Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review. Rheumatology 62:12, pages 3785-3800.
Crossref
Crossref
Francesco Amati, Gabriele Bongiovanni, Antonio Tonutti, Francesca Motta, Anna Stainer, Giuseppe Mangiameli, Stefano Aliberti, Carlo Selmi & Maria De Santis. (2023) Treatable Traits in Systemic Sclerosis. Clinical Reviews in Allergy & Immunology 65:2, pages 251-276.
Crossref
Crossref
Djúlio César Zanin-Silva, Maynara Santana-Gonçalves, Marianna Yumi Kawashima-Vasconcelos & Maria Carolina Oliveira. (2021) Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies. Frontiers in Medicine 8.
Crossref
Crossref
Kathryn S. Torok. (2021) Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma. Rheumatic Disease Clinics of North America 47:4, pages 757-780.
Crossref
Crossref
Cosimo Bruni, Laura Cometi, Antonietta Gigante, Edoardo Rosato & Marco Matucci-Cerinic. (2021) Prediction and primary prevention of major vascular complications in systemic sclerosis. European Journal of Internal Medicine 87, pages 51-58.
Crossref
Crossref
Michael Hughes, Cosimo Bruni, Barbara Ruaro, Marco Confalonieri, Marco Matucci-Cerinic & Silvia Bellando-Randone. (2021) Digital Ulcers in Systemic Sclerosis. La Presse Médicale 50:1, pages 104064.
Crossref
Crossref
Jessica G. Huffstuter & Bashar Kahaleh. 2021. Practical Management of Systemic Sclerosis in Clinical Practice. Practical Management of Systemic Sclerosis in Clinical Practice
79
99
.
Ellen S Satteson, Melody P Chung, Lorinda S Chung & James Chang. (2019) Microvascular hand surgery for digital ischemia in scleroderma. Journal of Scleroderma and Related Disorders 5:2, pages 130-136.
Crossref
Crossref
Colletti, Galardi, Santis, Guidelli, Giannatale, Luigi & Antinozzi. (2019) Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?. International Journal of Molecular Sciences 20:18, pages 4337.
Crossref
Crossref
Elizabeth R. Volkmann & John Varga. (2019) Emerging targets of disease-modifying therapy for systemic sclerosis. Nature Reviews Rheumatology 15:4, pages 208-224.
Crossref
Crossref
Sevdalina Lambova & Ulf Müller-Ladner. 2019. Genomic and Precision Medicine. Genomic and Precision Medicine
291
329
.
Thomas Stringer & Alisa N. Femia. (2018) Raynaud’s phenomenon: Current concepts. Clinics in Dermatology 36:4, pages 498-507.
Crossref
Crossref
Przemyslaw J. Kotyla. (2018) Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis. Journal of International Medical Research 46:5, pages 1893-1901.
Crossref
Crossref
Iván Cervigón González, Natalia Sánchez Neila, Silvia Montes García & Ángel Palomo Arellano. (2017) Algoritmo terapéutico del fenómeno de Raynaud y de las ulceraciones digitales isquémicas de la esclerodermia sistémica. Piel 32:6, pages 363-368.
Crossref
Crossref
Karim Ladak & Janet E. Pope. (2016) A review of the effects of statins in systemic sclerosis. Seminars in Arthritis and Rheumatism 45:6, pages 698-705.
Crossref
Crossref
Masataka Kuwana. 2016. Systemic Sclerosis. Systemic Sclerosis
39
56
.
Laura Cappelli & Fredrick M. Wigley. (2015) Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma. Rheumatic Disease Clinics of North America 41:3, pages 419-438.
Crossref
Crossref
Fernando V. Andrigueti, Maria I. Arismendi, Pâmela C.C. Ebbing & Cristiane Kayser. (2015) Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis. Microvascular Research 98, pages 82-87.
Crossref
Crossref
Marco Matucci-Cerinic, Bashar Kahaleh & Fredrick M. Wigley. (2013) Review: Evidence That Systemic Sclerosis Is a Vascular Disease. Arthritis & Rheumatism 65:8, pages 1953-1962.
Crossref
Crossref
Maurizio Cutolo, Alberto Sulli & Vanessa Smith. (2010) Assessing microvascular changes in systemic sclerosis diagnosis and management. Nature Reviews Rheumatology 6:10, pages 578-587.
Crossref
Crossref
M.O. Becker, U. Müller-Ladner & G. Riemekasten. (2010) Implementation von Leitlinien für eine Therapie der systemischen Sklerose (Sklerodermie)Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma). Zeitschrift für Rheumatologie 69:4, pages 310-317.
Crossref
Crossref